Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (4): 513-516    DOI: 10.12891/ceog3907.2018
Original Research Previous articles | Next articles
Impact of the oxytocin receptor antagonist atosiban administered shortly before embryo transfer on pregnancy rates after ICSI
S.A. Hebisha1, *(), Hisham M. Adel1
1 Department of Gynecology, Faculty of Medicine Alexandria University , Alexandria, Egypt
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To evaluate the impact of the oxytocin receptor antagonist atosiban on implantation and pregnancy rates after first ICSI trial in good prognosis cases. Design: Randomised controlled trial. Materials and Methods: The study included 182 women, prepared for first trial of ICSI for male or tubal factor infertility, using long agonist protocol, were randomized to receive 7.5 mg atosiban or placebo IV 20 minutes before embryo transfer (ET). Results: Fifty-eight (63.7%) cases had ongoing pregnancy in the study group while 44 (48.4%) cases had ongoing pregnancy in control group and this was statistically significant (p = 0.037). Implantation rates were 45.20%, and 34.69%, respectively, which was also statistically significant (p = 0.045). All of the intermediate cycle parameters were also comparable. Conclusion: Atosiban in the given dose and regimen improved both implantation and on going pregnancy rates in good prognosis cases undergoing first ICSI trial and blastocyst stage embryo transfer.
Key words:  Atosiban      Embryo transfer      ICSI      Clinical pregnancy rate     
Published:  10 August 2018     
*Corresponding Author(s):  S.A. HEBISHA     E-mail:  sherifanies@gmail.com

Cite this article: 

S.A. Hebisha, Hisham M. Adel. Impact of the oxytocin receptor antagonist atosiban administered shortly before embryo transfer on pregnancy rates after ICSI. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 513-516.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3907.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I4/513

[1] T. Hasegawa, K. Nakagawa, R. Sugiyama, N. Kuji, H. Nishi. Separate transfer of two frozen-thawed embryos reduces multiple gestations in assisted reproductive technology[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 215-219.
[2] H. Ye, S. Xue, Y. Kuang, L. Sun. A patient with non-mosaic 47, XXY karyotype fathering a normal healthy infant using intracytoplasmic sperm injection (ICSI) - a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 309-311.
[3] I. Gat, G. Raviv, M. Baum, R. Orvieto. MSOME and IMSI: reasonable rationale, selective clinical value[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 679-689.
[4] Shun Akaeda, Daiki Kobayashi, Kyoko Shioda, Mikio Momoeda. Relationship between serum progesterone concentrations and pregnancy rates in hormone replacement treatment-frozen embryo transfer using progesterone vaginal tablets[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 695-698.
[5] E.G. Aydeniz, U. Sari, T.U.K. Dilek. Pregnancy success rate at recurrent implantation failure patients after hysteroscopic endometrial injury: preliminary study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 709-712.
[6] P. Bakas, M. Simopoulou, P. Panagopoulos, N. Salakos, Ch. Siristatidis. Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 727-730.
[7] D. Summers, J.H. Check, R. Cohen, J.K. Choe. A live normal baby is possible despite exposure of a cleaving embryo in culture to extensive smoke and heat from a raging fire and exposure to chemicals used to extinguishing the fire[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 646-647.
[8] U. Indraccolo, G. Corona, M. Bonito, S.R. Indraccolo, E. Ferrazzi, R. Di Iorio. Selective medical treatment of heterotopic interstitial pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 656-657.
[9] Chunjuan Shen, Liping Wang, Xiaojie Wu, Shuhui Mao, Chunxia Fang. The relationship between vitamin D and IVF: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 12-15.
[10] Jianping Zhang, Fang Yang, Yaoqin Wang, Yonglian Wang, Hongmei Liang, Xueqing Wu. Effect of differential endometrial injury timing on frozen-thawed embryo transfer pregnancy outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 118-122.
[11] Turgut Aydin, Huseyin Aksoy, Ozge Idem Karadag, Ulku Aksoy, Elif Cinar. A comparative study on therapeutic outcomes and clinical implications of transvaginal and transabdominal guidance during embryo transfer[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 823-827.
[12] Bo Ma, Yuhu Li, Xiulan Zhang, Liuguang Zhang, Ning Li, Ping Yu. Supplementation of IVF solutions with melatonin improves assisted reproductive technology results[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 209-213.
[13] T. Miyamoto, K. Abiko, A. Itabashi, G. Minase, H. Ueda, K. Sengoku. MD-TESE-ICSI using fresh sperm resulted in a lower rate of miscarriage compared with frozen-thawed sperm[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 229-230.
[14] P. Bakas, M. Creatsa, P. Panagopoulos, N. Vlahos, E. Papadakis, M. Simopoulou. Outcome and recurrence risk of premature progesterone rise in IVF/ICSI cycles using GnRH antagonists for pituitary down-regulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 44-47.
[15] A.J. Jakimiuk, M.A. Nowicka, M. Zagozda, K. Koziol, P. Lewandowski, T. Issat. Levels of EG-VEGF and VEGF in serum and in the follicular fluid on the day of oocyte retrieval and reproductive outcome among IVF patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 93-97.
No Suggested Reading articles found!